Compare Global X Robo Global Robotics & Automation ETF (ROBO) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Global X Robo Global Robotics & Automation ETF vs Stryker Corporation — how do they compare? Global X Robo Global Robotics & Automation ETF trades at $79.45, while Stryker Corporation trades at $277.44 (market cap $105.63B). The key difference: Stryker Corporation pays a 1.28% dividend while Global X Robo Global Robotics & Automation ETF pays none, and Global X Robo Global Robotics & Automation ETF is trading nearer its 52-week high, Stryker Corporation nearer its low. Which is the better fit depends on your goals.
| ROBO | SYK | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $90.34 | $388.79 |
52-Week Low | $63.04 | $275.39 |
Market Cap | — | $105.63B |
Enterprise Value | — | $117.10B |
Dividend Yield | — | 1.28% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ROBO Global Robotics and Automation Index ETF trades at $79.65, down 1.14% over 24 hours, with technical indicators showing a bearish trend. The ETF provides diversified exposure to robotics and AI, with recent news highlighting accelerating adoption in manufacturing and military applications. Key support is at $80, with resistance at $81, while moving averages signal selling pressure.
The outlook for ROBO is supported by long-term growth in robotics adoption, but near-term risks include market volatility and high valuations. Investment opportunity lies in sector diversification, though investors face headwinds from economic cycles and competitive ETF offerings.
Stryker Corporation (SYK) trades at $276.43, down 8.81% over 24 hours, reflecting bearish technical signals but strong fundamentals. The stock shows robust profitability with a 14.43% net income margin and consistent earnings beats in recent quarters. Recent developments include the launch of an FDA-cleared surgical app for Apple Vision Pro and the acquisition of ZuriMED to expand shoulder care offerings. Analyst consensus remains strongly bullish with a $372.89 price target, though ongoing securities fraud investigations pose near-term sentiment risks.
Outlook is positive long-term due to solid financial health, innovation pipeline, and institutional support, but investors face volatility from legal probes and technical bearishness. The stock's current dip may present a buying opportunity for those confident in Stryker's market position and growth trajectory, balanced against regulatory and market risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Global X Robo Global Robotics & Automation ETF
ROBO is a thematic ETF that tracks the global robotics and automation industry. It provides diversified exposure to companies leading in industrial robotics, 3D printing, and surgical systems, with holdings like Intuitive Surgical and Zebra Technologies.
Read more on ROBO →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
